Stockreport

LAVA Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference [Yahoo! Finance]

LAVA Therapeutics N.V. - Ordinary Shares  (LVTX) 
PDF of bispecific gamma delta T cell engagers, today announced that Stephen Hurly, President and Chief Executive Officer of LAVA Therapeutics, will present at the H.C. Wainw [Read more]